These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36210341)

  • 1. Discovery and Structural Explorations of G-Protein Biased μ-Opioid Receptor Agonists.
    Li X; Guo Y; Li J; Yu Z; Cheng J; Ren F; Jia H; Zhang Y; Cui S; Zhang T; Shi W
    ChemMedChem; 2022 Dec; 17(24):e202200416. PubMed ID: 36210341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists.
    Ma M; Sun J; Li M; Yu Z; Cheng J; Zhong B; Shi W
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Based Evolution of G Protein-Biased μ-Opioid Receptor Agonists.
    Wang H; Hetzer F; Huang W; Qu Q; Meyerowitz J; Kaindl J; Hübner H; Skiniotis G; Kobilka BK; Gmeiner P
    Angew Chem Int Ed Engl; 2022 Jun; 61(26):e202200269. PubMed ID: 35385593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor.
    Mafi A; Kim SK; Goddard WA
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16346-16355. PubMed ID: 32601232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular recognition of morphine and fentanyl by the human μ-opioid receptor.
    Zhuang Y; Wang Y; He B; He X; Zhou XE; Guo S; Rao Q; Yang J; Liu J; Zhou Q; Wang X; Liu M; Liu W; Jiang X; Yang D; Jiang H; Shen J; Melcher K; Chen H; Jiang Y; Cheng X; Wang MW; Xie X; Xu HE
    Cell; 2022 Nov; 185(23):4361-4375.e19. PubMed ID: 36368306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Biased Mu-Opioid Receptor Agonists for the Treatment of Pain.
    Ma M; Li X; Tong K; Cheng J; Yu Z; Ren F; Zhong B; Shi W
    ChemMedChem; 2020 Jan; 15(1):155-161. PubMed ID: 31729174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based discovery of opioid analgesics with reduced side effects.
    Manglik A; Lin H; Aryal DK; McCorvy JD; Dengler D; Corder G; Levit A; Kling RC; Bernat V; Hübner H; Huang XP; Sassano MF; Giguère PM; Löber S; Da Duan ; Scherrer G; Kobilka BK; Gmeiner P; Roth BL; Shoichet BK
    Nature; 2016 Sep; 537(7619):185-190. PubMed ID: 27533032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biased versus Partial Agonism in the Search for Safer Opioid Analgesics.
    Azevedo Neto J; Costanzini A; De Giorgio R; Lambert DG; Ruzza C; Calò G
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32854452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological, and structural explorations of a series of μ-opioid receptor (MOR) agonists with high G protein signaling bias.
    Yang Y; Wang Y; Zuo A; Li C; Wang W; Jiang W; Zhang X; Che X; Zhang Y; Wu W; Cen X; Wang H; Tian J
    Eur J Med Chem; 2022 Jan; 228():113986. PubMed ID: 34802839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
    Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
    Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Biological Evaluation of Novel Biased Mu-Opioid Receptor Agonists.
    Guo Y; Yu R; Zhang T; Ren F; Yu Z; Cheng J; Jia H; Shi W; Zhang Y
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38998913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.
    Groer CE; Tidgewell K; Moyer RA; Harding WW; Rothman RB; Prisinzano TE; Bohn LM
    Mol Pharmacol; 2007 Feb; 71(2):549-57. PubMed ID: 17090705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available μ-opioid receptor number.
    Singleton S; Baptista-Hon DT; Edelsten E; McCaughey KS; Camplisson E; Hales TG
    Br J Pharmacol; 2021 Apr; 178(8):1855-1868. PubMed ID: 33555037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing Allosteric Regulation Mechanism of W7.35 on Agonist-Induced Activity for μOR by Mutation Simulation.
    Zhang F; Chen X; Chen J; Xu Y; Li S; Guo Y; Pu X
    J Chem Inf Model; 2022 Nov; 62(21):5120-5135. PubMed ID: 34779608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor.
    Gillis A; Kliewer A; Kelly E; Henderson G; Christie MJ; Schulz S; Canals M
    Trends Pharmacol Sci; 2020 Dec; 41(12):947-959. PubMed ID: 33097283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of pyrazole-1-carboxamide derivatives as novel Gi-biased μ-opioid receptor agonists.
    Jung JH; Jang IH; Kim YO; Kim S; Yoon MH; Kim YC
    Drug Dev Res; 2022 Nov; 83(7):1600-1612. PubMed ID: 36124859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates.
    Ding H; Kiguchi N; Perrey DA; Nguyen T; Czoty PW; Hsu FC; Zhang Y; Ko MC
    Br J Anaesth; 2020 Oct; 125(4):596-604. PubMed ID: 32819621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
    Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
    Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.
    Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M
    Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances.
    Vandeputte MM; Cannaert A; Stove CP
    Arch Toxicol; 2020 Nov; 94(11):3819-3830. PubMed ID: 32734307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.